FDA

FDA Reviewers Found Accepting Industry Payments After Drug Approvals

By Alan, on July 6th, 2018%

A new report finds a large percentage of panel members that review drug applications for the Food and Drug Administration accept payments and other rewards from companies after their drugs are approved. . . . → Read More: FDA Reviewers Found Accepting Industry Payments After Drug Approvals

Cannabis Drug Approved by FDA for Rare, Severe Seizures

By Alan, on June 26th, 2018%

A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy. . . . → Read More: Cannabis Drug Approved by FDA for Rare, Severe Seizures

FDA Issues Guidance on Patient Experience Data Collection

By Alan, on June 13th, 2018%

The Food and Drug Administration issued draft regulatory guidance outlining methods for collecting data from patients that the agency says will help improve evaluations of more precisely targeted drugs. . . . → Read More: FDA Issues Guidance on Patient Experience Data Collection

FDA Delays Crispr Trial for Inherited Blood Diseases

By Alan, on May 31st, 2018%

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

New ALS Drug Formula Shown Active, Safe

By Alan, on May 29th, 2018%

A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe

FDA Okays A.I.-Guided Wrist Fracture Software

By Alan, on May 25th, 2018%

The U.S. Food and Drug Administration authorized marketing of software to help diagnose wrist fractures using machine-learning algorithms to read and interpret X-ray images. . . . → Read More: FDA Okays A.I.-Guided Wrist Fracture Software

FDA Urges More Industry Sun Protection Research

By Alan, on May 23rd, 2018%

The head of the U.S. Food and Drug Administration is asking companies making sunscreen to conduct more research on the safety of products that protect against harmful sun rays. . . . → Read More: FDA Urges More Industry Sun Protection Research

Cannabis Derivative Shown to Reduce Severe Seizures

By Alan, on May 17th, 2018%

A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs. . . . → Read More: Cannabis Derivative Shown to Reduce Severe Seizures

Clinical Trials Okayed for Sickle Cell Gene Editing

By Alan, on May 16th, 2018%

Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing. . . . → Read More: Clinical Trials Okayed for Sickle Cell Gene Editing

FDA Clears A.I. Software Detecting Diabetic Eye Disease

By Alan, on April 11th, 2018%

The Food and Drug Administration authorized a system for detecting diabetic retinopathy, a condition threatening the vision of people with diabetes, that uses artificial intelligence to analyze images of patients’ retinas. . . . → Read More: FDA Clears A.I. Software Detecting Diabetic Eye Disease

Science & Enterprise subscription

Guest Posts

Please share Science & Enterprise

Specials

Search by tag

FDA Reviewers Found Accepting Industry Payments After Drug Approvals

Cannabis Drug Approved by FDA for Rare, Severe Seizures

FDA Issues Guidance on Patient Experience Data Collection

FDA Delays Crispr Trial for Inherited Blood Diseases

New ALS Drug Formula Shown Active, Safe

FDA Okays A.I.-Guided Wrist Fracture Software

FDA Urges More Industry Sun Protection Research

Cannabis Derivative Shown to Reduce Severe Seizures

Clinical Trials Okayed for Sickle Cell Gene Editing

FDA Clears A.I. Software Detecting Diabetic Eye Disease

Welcome to Science & Enterprise

Here’s what’s new …

Follow us on Facebook

Alan Kotok’s articles on

Affiliations